Jump to content

South African AIDS Vaccine Initiative

From Wikipedia, the free encyclopedia

The South African AIDS Vaccine Initiative (SAAVI) was a South African organisation with the mission of coordinating the research and development of HIV vaccines in and for South Africa.[1][2] The organization closed on 31 December 2012.[3]

History

[edit]

SAAVI was established in 1999 by the South African government as a project of the South African Medical Research Council.[1] SAAVI frequently partnered with the HIV Vaccine Trials Network.[1]

Funding problems

[edit]

In June 2009, SAAVI announced that it was testing a new HIV vaccine candidate but suspended all further vaccine development indefinitely due to lack of funds.[4]

References

[edit]
  1. ^ a b c Tucker, Timothy J; Mazithulela, Gatsha (21 August 2004). "Development of an AIDS vaccine: perspective from the South African AIDS Vaccine Initiative". BMJ: British Medical Journal. 329 (7463): 454–456. doi:10.1136/bmj.329.7463.454. ISSN 0959-8138. PMC 514216. PMID 15321907.
  2. ^ Birmingham, Karen (1 August 2000). "HIV vaccine trials planned for Africa". Nature Medicine. 6 (8): 844. doi:10.1038/78569. ISSN 1546-170X. PMID 10932201.
  3. ^ "SAAVI". saavi.org.za.
  4. ^ Faul, Michelle (20 June 2009). "South Africa launches AIDS vaccine trial but slashes research funding". washingtonexaminer.com. Washington Examiner. Retrieved 24 June 2011.
[edit]